Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1

2(66.7%)

N/A

1(33.3%)

3Total

Phase 1(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04677998Recruiting

A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis

Role: collaborator

NCT04678011Recruiting

A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy

Role: collaborator

NCT06958497Completed

Safety, Efficacy and Quality of Life of Sphinkeeper Implantation for Fecal Incontinence

Role: collaborator

NCT02941471Phase 1Completed

Transabdominal Electrical Stimulation for Constipation

Role: lead

NCT00180648Completed

Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure

Role: collaborator

NCT00733876Phase 1Completed

Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac Surgery

Role: collaborator

NCT00212420Not ApplicableUnknown

Nutritional Management of Acute and Chronic Enterocutaneous Fistulae

Role: collaborator

NCT00138879Completed

Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients

Role: lead

All 8 trials loaded